Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rewiring of mitochondrial metabolism in therapy-resistant cancers: permanent and plastic adaptations
Katherine E. Pendleton, Karen Wang, Gloria V. Echeverria
Frontiers in Cell and Developmental Biology (2023) Vol. 11
Open Access | Times Cited: 18

Showing 18 citing articles:

Targeting Metabolic Vulnerabilities to Combat Drug Resistance in Cancer Therapy
Taranatee Khan, M Nagarajan, Irene Kang, et al.
Journal of Personalized Medicine (2025) Vol. 15, Iss. 2, pp. 50-50
Open Access
Complex II ambiguities—FADH2 in the electron transfer system
Erich Gnaiger
Journal of Biological Chemistry (2023) Vol. 300, Iss. 1, pp. 105470-105470
Open Access | Times Cited: 15
Targeting metabolic adaptive responses induced by glucose starvation inhibits cell proliferation and enhances cell death in osimertinib-resistant non-small cell lung cancer (NSCLC) cell lines
Kamal Eltayeb, Roberta Alfieri, Claudia Fumarola, et al.
Biochemical Pharmacology (2024) Vol. 228, pp. 116161-116161
Open Access | Times Cited: 3
Targeting PARP14 with lomitapide suppresses drug resistance through the activation of DRP1-induced mitophagy in multiple myeloma
Honghao Zhang, Hao Wang, Yuxing Hu, et al.
Cancer Letters (2024) Vol. 588, pp. 216802-216802
Closed Access | Times Cited: 2
PGC-1α drives small cell neuroendocrine cancer progression towards an ASCL1-expressing subtype with increased mitochondrial capacity
Grigor Varuzhanyan, Chia‐Chun Chen, Jack Freeland, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 2
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition
Luca Ponzone, Valentina Audrito, Claudia Landi, et al.
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 2
The Bright Side of Curcumin: A Narrative Review of Its Therapeutic Potential in Cancer Management
Andrea Amaroli, Isabella Panfoli, Matteo Bozzo, et al.
Cancers (2024) Vol. 16, Iss. 14, pp. 2580-2580
Open Access | Times Cited: 2
Oxidative Phosphorylation as a Predictive Biomarker of Oxaliplatin Response in Colorectal Cancer
Toni Martínez-Bernabé, Daniel Gabriel Pons, Jordi Oliver, et al.
Biomolecules (2024) Vol. 14, Iss. 11, pp. 1359-1359
Open Access | Times Cited: 2
Malate dehydrogenase (MDH) in cancer: a promiscuous enzyme, a redox regulator, and a metabolic co-conspirator
Betsy D. Leverett, Shane Austin, Jason Tan-Arroyo
Essays in Biochemistry (2024)
Closed Access | Times Cited: 1
Ferroptosis susceptibility of melanoma cells: dependence on cell-type, acquired drug resistance, and medium composition
Jasmin Renate Preis, Catherine Rolvering, Mélanie Kirchmeyer, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Deregulation of mitochondrial gene expression in cancer: mechanisms and therapeutic opportunities
Mariah J. Berner, Steven W. Wall, Gloria V. Echeverria
British Journal of Cancer (2024) Vol. 131, Iss. 9, pp. 1415-1424
Closed Access | Times Cited: 1
Three-dimensional analysis of mitochondria in a patient-derived xenograft model of triple negative breast cancer reveals mitochondrial network remodeling following chemotherapy treatments
Mariah J. Berner, Heather K. Beasley, Zer Vue, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 1
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Mary Priyanka Udumula, Faraz Rashid, Harshit Singh, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Characterization of mitochondrial metabolism related molecular subtypes and immune infiltration in colorectal adenocarcinoma
Meng Wang, Lingkai Xue, Zhenghua Fei, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access
Targeting mitochondrial metabolism with CPI-613 in chemoresistant ovarian tumors
Mary Priyanka Udumula, Faraz Rashid, Harshit Singh, et al.
Journal of Ovarian Research (2024) Vol. 17, Iss. 1
Open Access
Metabolism‐focused CRISPR screen unveils mitochondrial pyruvate carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
Takashi Furusawa, Renzo Cavero, Yue Liu, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 6, pp. 1024-1037
Open Access
PARP-1 negatively regulates nucleolar protein pool and mitochondrial activity: a cell protective mechanism
Atanu Ghorai, Soumajit Saha, Basuthkar J. Rao
Genes and Environment (2024) Vol. 46, Iss. 1
Open Access
Metabolism-focused CRISPR screen unveils Mitochondrial Pyruvate Carrier 1 as a critical driver for PARP inhibitor resistance in lung cancer
Takashi Furusawa, Renzo Cavero, Yue Liu, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Page 1

Scroll to top